Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xuefeng Fang, Dr
CONTACT
Lead
Second Affiliated Hospital, Zhejiang University, School of Medicine
This study is a single arm, open label, single center clinical study aimed at evaluating the efficacy and safety of candenizumab combined with chemotherapy and targeted drugs (cetuximab or bevacizumab) in second-line treatment of MSS type advanced metastatic colorectal cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted